DE2607627A1 - 1-0-acetoxybenzoyl-4-hydroxy-l-prolin sowie 1-0-acetoxybenzoyl-l-prolin, verfahren zu ihrer herstellung und ihre verwendung als medikament - Google Patents

1-0-acetoxybenzoyl-4-hydroxy-l-prolin sowie 1-0-acetoxybenzoyl-l-prolin, verfahren zu ihrer herstellung und ihre verwendung als medikament

Info

Publication number
DE2607627A1
DE2607627A1 DE19762607627 DE2607627A DE2607627A1 DE 2607627 A1 DE2607627 A1 DE 2607627A1 DE 19762607627 DE19762607627 DE 19762607627 DE 2607627 A DE2607627 A DE 2607627A DE 2607627 A1 DE2607627 A1 DE 2607627A1
Authority
DE
Germany
Prior art keywords
proline
acetoxybenzoyl
hydroxy
reaction
medium
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
DE19762607627
Other languages
German (de)
English (en)
Inventor
Andre Prof Jondet
Henri Kornowski
Robert Dipl Chem Oberlin
Bernard Prof Roques
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merrell Toraude et Cie
Original Assignee
Merrell Toraude et Cie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Toraude et Cie filed Critical Merrell Toraude et Cie
Publication of DE2607627A1 publication Critical patent/DE2607627A1/de
Withdrawn legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/16Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pain & Pain Management (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
DE19762607627 1975-06-02 1976-02-25 1-0-acetoxybenzoyl-4-hydroxy-l-prolin sowie 1-0-acetoxybenzoyl-l-prolin, verfahren zu ihrer herstellung und ihre verwendung als medikament Withdrawn DE2607627A1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7517140A FR2346015A2 (fr) 1975-06-02 1975-06-02 O-acetoxybenzoyl-1-l-proline, son procede de preparation et son utilisation comme medicament

Publications (1)

Publication Number Publication Date
DE2607627A1 true DE2607627A1 (de) 1976-12-23

Family

ID=9155944

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19762607627 Withdrawn DE2607627A1 (de) 1975-06-02 1976-02-25 1-0-acetoxybenzoyl-4-hydroxy-l-prolin sowie 1-0-acetoxybenzoyl-l-prolin, verfahren zu ihrer herstellung und ihre verwendung als medikament

Country Status (6)

Country Link
JP (1) JPS6011693B2 (fr)
BE (1) BE839102A (fr)
DD (1) DD124381A5 (fr)
DE (1) DE2607627A1 (fr)
ES (1) ES445395A1 (fr)
FR (1) FR2346015A2 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS4987042A (fr) * 1972-12-26 1974-08-20
JPS6437398U (fr) * 1987-08-28 1989-03-07
WO2006046690A1 (fr) * 2004-10-28 2006-05-04 Kyowa Hakko Kogyo Co., Ltd. Préparation pour cavité orale

Also Published As

Publication number Publication date
BE839102A (fr) 1976-07-01
JPS6011693B2 (ja) 1985-03-27
JPS525759A (en) 1977-01-17
FR2346015B2 (fr) 1979-01-05
FR2346015A2 (fr) 1977-10-28
ES445395A1 (es) 1977-06-01
DD124381A5 (fr) 1977-02-16

Similar Documents

Publication Publication Date Title
EP0013376A2 (fr) Dérivé d'isoxazole, procédé pour sa préparation et composition le contenant
DE2414680C2 (de) Substituierte 2-Furancarbonsäuren und 2-Furancarbonsäureester, Verfahren zu ihrer Herstellung und Arzneimittel, die diese Verbindungen enthalten
DE1795792A1 (de) Die serumlipoidkonzentration vermindernde arzneimittel
DE2414273C3 (de) N-Methyl-D-glucaminsalz von 2-(2'-Methyl-3'-trifluormethyl-anilin)-nicotinsäure, Verfahren zu seiner Herstellung und es enthaltende Arzneimittelzubereitung
DE2005454A1 (de) Neue Naphthylpropionsäurederivate und Verfahren zu ihrer Herstellung und Verwendung
DE1670005C2 (de) β-(4,5-Diphenyloxazol-2-yl)-propionsäure oder ein pharmazeutisch verträgliches Salz davon, Verfahren zur Herstellung dieser Verbindungen und pharmazeutische Zubereitungen, welche diese Verbindungen enthalten
DE2434929C2 (de) p-Acetylaminophenolester von Phenylsalicylsäuren, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
DE2607627A1 (de) 1-0-acetoxybenzoyl-4-hydroxy-l-prolin sowie 1-0-acetoxybenzoyl-l-prolin, verfahren zu ihrer herstellung und ihre verwendung als medikament
DE2804293C2 (fr)
DE2038628C3 (de) N,N'-Di(carboxyalkyI)-p-phenylendiamine, deren Salze und Diäthylester, Verfahren zu ihrer Herstellung und ihre Verwendung
DE2748291A1 (de) Triglyceride, verfahren zu ihrer herstellung und ihre verwendung zur behandlung von entzuendungen
DE2318784A1 (de) N-(2,4-dihydroxybenzoyl)-4-aminosalizylsaeure
DE2253914A1 (de) Neue chromonderivate und verfahren zu ihrer herstellung
DE2320945A1 (de) Neue ester der acetylsalicylsaeure
DE2038836C3 (de) Arzneimittel
DE3005359C2 (de) N-m-Trifluormethylphenylanthranilate von o-Alkoxycarbonylphenolen, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel
DE2901914C2 (de) Zinksalz der 6-N-Acetylamino-capronsäure, Verfahren zu dessen Herstellung und diese Verbindung enthaltende Arzneimittel
DE2408372C3 (de) Therapeutisch verträgliche Salze der p-Chlorhippursäure und diese oder p-Chlorhippursäure enthaltende pharmazeutische Zubereitungen
DE2322125A1 (de) Substituierte 1-hydroxy-3-(2-naphthyl) ketone und deren derivate
DE1936747C3 (de) 1,2-Diphenyl-4-n-butyl-4-hydroxymethyl-S.S-dioxopyrazolidin-halbsuccinat
DE2148986B2 (de) Salze der Chondroitinschwefelsäure mit Carboxymethyl-trimethylammoniumhydroxid, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
DE3634989C2 (de) Verfahren zur Herstellung von substituierten Bisphenolen
DE1543792C (de) Monophosphorsäureester von 2,2 Biphenolen sowie Verfahren zu ihrer Her stellung
DE1770157C3 (de) Argininsalz der l-p-Chlorbenzoyl-2-methyl-5-methoxy-3-indolylessigsäure
DE2930039A1 (de) Entzuendungshemmendes mittel

Legal Events

Date Code Title Description
8110 Request for examination paragraph 44
8130 Withdrawal